Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00938782 · ClinicalTrials.gov registry record · Phase 4

Using the SEDLine for the Titration of Sevoflurane in Elderly Patients Recovery Using the SEDLine TM for the Titration of Sevoflurane in Elderly Patients Undergoing Non-Cardiac Surgery After Beta-Adrenergic Blockade

A Phase 4 study of Anesthesia, General, sponsored by Stanford University.

Completed
Registry status
Phase 4
Development phase
67
Enrollment target
2
Study locations

NCT00938782 is a Phase 4 study of Anesthesia, General that has completed, run by Stanford University. The registered enrollment target is 67 participants. The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00938782, a Phase 4 study of Anesthesia, General, has completed, sponsored by Stanford University.

COMPLETED
Registry status
Phase 4
Development phase
67 participants
Enrollment target
2
Study locations

Study Summary

Asses the effect of the use of Patient State Index (PSI) monitoring on difference in emergence profiles in the elderly (age \>65 yrs) population to develop a cost-benefit profile. Assess differences in Quality of Life using the QoR-40 (a validated 40-item questionnaire on quality of recovery from anesthesia) between the two treatment groups.

Conditions Studied

Interventions

  • DEVICE Sedline

Study Locations (2)

California

  • Stanford University School of Medicine - Stanford

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 67 participants
Start Date 2006-07
Est. Completion 2012-06
Phase Phase 4

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT00938782

The ClinicalTrials.gov registry entry for NCT00938782 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anesthesia, General appearing as the primary indexed condition, and to 1 intervention - of which Sedline is the first listed.

NCT00938782 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00938782 about?

NCT00938782 is a clinical study titled "Using the SEDLine for the Titration of Sevoflurane in Elderly Patients Recovery Using the SEDLine TM for the Titration of Sevoflurane in Elderly Patients Undergoing Non-Cardiac Surgery After Beta-Adrenergic Blockade". Asses the effect of the use of Patient State Index (PSI) monitoring on difference in emergence profiles in the elderly (age \>65 yrs) population to develop a cost-benefit profile. Assess differences in Quality of Life using the QoR-40 (a validated 40-item questionnaire on quality of recovery from a...

What is the current status of trial NCT00938782?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 67 participants. The study started on 2006-07. Estimated completion is 2012-06.

What conditions does trial NCT00938782 study?

This clinical trial studies the following conditions: Anesthesia, General.

What interventions are being tested in trial NCT00938782?

The interventions under investigation include: Sedline (DEVICE).

Who is sponsoring clinical trial NCT00938782?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00938782 being conducted?

This trial has 2 study locations across California, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anesthesia, General

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.